Introduction: Extended total nephrectomy (ENT) is the treatment for localized or locally advanced renal cancer with vena cava tumor thrombus. The existence of a vena cava thrombus imposes a vascular surgery time which increases the intraoperative mortality and morbidity. Purpose: the purpose of this clinical case and to evaluate our surgical management of non-metastatic renal cancer with subdiaphragmatic vena cava thrombus. Observation: This was a 63-year-old patient who had presented disabling right low back pain associated with macroscopic haematuria no signs of deglobulization on biological examination. The morphological assessment was carried out using an abdominal computed tomography, which revealed a right kidney tumor classified as T3bN1. A tumor extension assessment by thoracic computed tomography was performed afterwards. There were no remote secondary lesions (M0). After CPR discussion, we performed ENT with lymph node dissection associated with inferior vena cava thrombectomy. The post-operative follow-up had been simple. Controls were carried out at 1 month then every 6 months for 1 year and every year for 5 years. There was no local, loco regional or distant recurrence. Conclusion: Kidney cancer with non-metastatic vena cava thrombus represents a locally advanced form whose surgical management must be well assessed, in terms of the increased risk of perioperative morbidity and mortality.
| Published in | International Journal of Clinical Urology (Volume 6, Issue 2) |
| DOI | 10.11648/j.ijcu.20220602.11 |
| Page(s) | 66-70 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Renal Carcinoma, Venous Thrombus, Extended Total Nephrectomy
| [1] | Kakoti S, Jena R, Sureka SK, Srivastava A, Mandhani A, Singh UP. Experience with management of renal cell carcinoma with inferior vena cava/right atrial tumor thrombus. Indian J Urol. 2021 Jul-Sep; 37 (3): 234-240. doi: 10.4103/iju.IJU_13_21. Epub 2021 Jul 1. PMID: 34465952; PMCID: PMC8388349. |
| [2] | Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. Urol Oncol. 2019 Sep; 37 (9): 577.e9-577.e16. |
| [3] | Burotto M, Renner A. Nephrectomy in metastatic renal cell carcinoma with venous thrombus: more thrombus equals less benefit? Ann Transl Med. 2019 Sep; 7 (Suppl 6): S186. |
| [4] | Onal B, Simsekoglu MF, Gultekin MH, Demirdag C, Citgez S, Erozenci A. Clinical outcomes of radical surgery in patients with renal carcinoma and associated venous thrombosis: Single-centre experience in a tertiary care institution. Int J Clin Pract. 2021 Apr; 75 (4): e13811. |
| [5] | Zhang Y, Tian X, Bi H, Hong P, Liu Z, Yan Y, Liu C, Ma L. Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center. J Oncol. 2022 Mar 17; 2022: 9191659. |
| [6] | Ueki H, Terakawa T, Ueno Y, Sofue K, Horii S, Okamura Y, Bando Y, Hara T, Furukawa J, Harada K, Hinata N, Nakano Y, Murakami T, Fujisawa M. Efficacy of preoperative cine magnetic resonance imaging in evaluation of adhesion of renal cancer thrombus to inferior vena cava wall. J Vasc Surg Venous Lymphat Disord. 2022 Mar 18: S2213-333X (22)00101-9. |
| [7] | Nini A, Muttin F, Cianflone F, Carenzi C, Luciano R, Catena M, Larcher A, Salvioni M, Cazzaniga W, Pederzoli F, Matloob R, Colombo R, Paganelli M, Salonia A, Briganti A, Doglioni C, Zangrillo A, DE Cobelli F, Rigatti P, Freschi M, Cornero G, Nicoletti R, Aldrighetti L, Montorsi F, Capitanio U, Bertini R. Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience. Minerva Urol Nephrol. 2021 Dec; 73 (6): 746-753. |
| [8] | Shemshaki H, Al-Mamari SA, Al-Hooti Q, Geelani IA, Al Salmi I, Narayana Kurukkal S, Kumar S, Al Julandani A, Sadeghzadeh S. Comparison of cytoreductive partial versus radical nephrectomy in metastatic renal cell carcinoma: To be on the horns of a dilemma. Urologia. 2022 May; 89 (2): 160-166. |
| [9] | Abel EJ, Spiess PE, Margulis V, Master VA, Mann M, Zargar-Shoshtari K, Borregales LD, Sexton WJ, Patil D, Matin SF, Wood CG, Karam JA. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus. J Urol. 2017 Aug; 198 (2): 281-288. |
| [10] | Soares A, Maia MC, Vidigal F, Marques Monteiro FS. Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: How to Apply New Evidence in Clinical Practice. Oncology. 2020; 98 (1): 1-9. |
| [11] | Topaktaş R, Ürkmez A, Tokuç E, Kayar R, Kanberoğlu H, Öztürk Mİ. Surgical management of renal cell carcinoma with associated tumor thrombus extending into the inferior vena cava: A 10-year single-center experience. Turk J Urol. 2019 Feb 4; 45 (5): 345-350. |
| [12] | Guo B, Liu S, Wang M, Hou H, Liu M. The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis. Bosn J Basic Med Sci. 2021 Apr 1; 21 (2): 229-234. |
| [13] | Bensalah K, Bigot P, Albiges L, Bernhard JC, Bodin T, Boissier R, Correas JM, Gimel P, Hetet JF, Long JA, Nouhaud FX, Ouzaïd I, Rioux-Leclercq N, Méjean A. ccAFU guidelines - update 2020-2022: management of kidney cancer. Prog Urol. 2020 Nov; 30 (12S): S2-S51. |
| [14] | Chen Z, Yang F, Ge L, Qiu M, Liu Z, Liu C, Tian X, Zhang S, Ma L. Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center. BMC Cancer. 2021 Jul 2; 21 (1): 766. |
| [15] | Jurado A, Romeo A, Gueglio G, Marchiñena PG. Current Trends in Management of Renal Cell Carcinoma with Venous Thrombus Extension. Curr Urol Rep. 2021 Feb 8; 22 (4): 23. |
| [16] | Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, and all. KEYNOTE-564 Investigators. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med. 2021 Aug 19; 385 (8): 683-694. |
APA Style
Smith Giscard Olagui, Mariette Nsa Bidzo, Ulrich Davy Ngabou, Ernest Belembaogo. (2022). Nephrectomy for No Metastatic Renal Cell Carcinoma with Venous Tumor Thrombus About One Case and Literature Review. International Journal of Clinical Urology, 6(2), 66-70. https://doi.org/10.11648/j.ijcu.20220602.11
ACS Style
Smith Giscard Olagui; Mariette Nsa Bidzo; Ulrich Davy Ngabou; Ernest Belembaogo. Nephrectomy for No Metastatic Renal Cell Carcinoma with Venous Tumor Thrombus About One Case and Literature Review. Int. J. Clin. Urol. 2022, 6(2), 66-70. doi: 10.11648/j.ijcu.20220602.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcu.20220602.11,
author = {Smith Giscard Olagui and Mariette Nsa Bidzo and Ulrich Davy Ngabou and Ernest Belembaogo},
title = {Nephrectomy for No Metastatic Renal Cell Carcinoma with Venous Tumor Thrombus About One Case and Literature Review},
journal = {International Journal of Clinical Urology},
volume = {6},
number = {2},
pages = {66-70},
doi = {10.11648/j.ijcu.20220602.11},
url = {https://doi.org/10.11648/j.ijcu.20220602.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20220602.11},
abstract = {Introduction: Extended total nephrectomy (ENT) is the treatment for localized or locally advanced renal cancer with vena cava tumor thrombus. The existence of a vena cava thrombus imposes a vascular surgery time which increases the intraoperative mortality and morbidity. Purpose: the purpose of this clinical case and to evaluate our surgical management of non-metastatic renal cancer with subdiaphragmatic vena cava thrombus. Observation: This was a 63-year-old patient who had presented disabling right low back pain associated with macroscopic haematuria no signs of deglobulization on biological examination. The morphological assessment was carried out using an abdominal computed tomography, which revealed a right kidney tumor classified as T3bN1. A tumor extension assessment by thoracic computed tomography was performed afterwards. There were no remote secondary lesions (M0). After CPR discussion, we performed ENT with lymph node dissection associated with inferior vena cava thrombectomy. The post-operative follow-up had been simple. Controls were carried out at 1 month then every 6 months for 1 year and every year for 5 years. There was no local, loco regional or distant recurrence. Conclusion: Kidney cancer with non-metastatic vena cava thrombus represents a locally advanced form whose surgical management must be well assessed, in terms of the increased risk of perioperative morbidity and mortality.},
year = {2022}
}
TY - JOUR T1 - Nephrectomy for No Metastatic Renal Cell Carcinoma with Venous Tumor Thrombus About One Case and Literature Review AU - Smith Giscard Olagui AU - Mariette Nsa Bidzo AU - Ulrich Davy Ngabou AU - Ernest Belembaogo Y1 - 2022/07/20 PY - 2022 N1 - https://doi.org/10.11648/j.ijcu.20220602.11 DO - 10.11648/j.ijcu.20220602.11 T2 - International Journal of Clinical Urology JF - International Journal of Clinical Urology JO - International Journal of Clinical Urology SP - 66 EP - 70 PB - Science Publishing Group SN - 2640-1355 UR - https://doi.org/10.11648/j.ijcu.20220602.11 AB - Introduction: Extended total nephrectomy (ENT) is the treatment for localized or locally advanced renal cancer with vena cava tumor thrombus. The existence of a vena cava thrombus imposes a vascular surgery time which increases the intraoperative mortality and morbidity. Purpose: the purpose of this clinical case and to evaluate our surgical management of non-metastatic renal cancer with subdiaphragmatic vena cava thrombus. Observation: This was a 63-year-old patient who had presented disabling right low back pain associated with macroscopic haematuria no signs of deglobulization on biological examination. The morphological assessment was carried out using an abdominal computed tomography, which revealed a right kidney tumor classified as T3bN1. A tumor extension assessment by thoracic computed tomography was performed afterwards. There were no remote secondary lesions (M0). After CPR discussion, we performed ENT with lymph node dissection associated with inferior vena cava thrombectomy. The post-operative follow-up had been simple. Controls were carried out at 1 month then every 6 months for 1 year and every year for 5 years. There was no local, loco regional or distant recurrence. Conclusion: Kidney cancer with non-metastatic vena cava thrombus represents a locally advanced form whose surgical management must be well assessed, in terms of the increased risk of perioperative morbidity and mortality. VL - 6 IS - 2 ER -
Information
Email: